miR-494-3p modulates the progression of in vitro and in vivo Parkinson’s disease models by targeting SIRT3
Sign Up to like & getrecommendations! Published in 2018 at "Neuroscience Letters"
DOI: 10.1016/j.neulet.2018.03.037
Abstract: Parkinson's disease (PD) is the second most prevalent chronic and progressive neurodegenerative disease. Plenty of miRNAs have been demonstrated to participate in the pathogenesis of PD. However, the detailed roles of miR-494-3p and underlying mechanisms… read more here.
Keywords: mir 494; targeting sirt3; disease; expression ... See more keywords